Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Plethora studies PSD-597 as analgesic therapy in urogynecological procedures

Feb. 13, 2007

GSK and Fabre-Kramer sign global agreement for gepirone ER

Feb. 13, 2007

GSK and XenoPort sign agreement for XP-13512

Feb. 13, 2007

Recent Banyu patent imparts novel analgesic agents

Feb. 13, 2007

SRI and Telik sign agreement for C-243

Feb. 12, 2007

SCOLR Pharma reports outcomes for CDT-based therapies

Feb. 12, 2007

CytRx to determine maximum dose of arimoclomol

Feb. 12, 2007

Allon Therapeutics outlines recent progress and upcoming milestones

Feb. 12, 2007

Recent patents disclose new antidepressive, antipsychotic and anxiolytic agents

Feb. 12, 2007

Snapshots of studies from the International Neuropsychological Society meeting

Feb. 12, 2007

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...